For all the above-mentioned modifications to MRLs for cyflumetofen, oxathiapiprolin and pyraclostrobin requested by the applicants, the Authority concluded that all the data requirements had been met and that the modifications to the MRLs requested by the applicants were acceptable with regard to consumer safety on the basis of a consumer exposure assessment for 27 specific European consumer groups. In so concluding, the Authority took into account the most recent data on the toxicological properties of the substances. Neither the long-term exposure to these substances via consumption of all food products that may contain them nor the short-term exposure due to high consumption of relevant products show a risk that the acceptable daily intake or the acute reference dose is exceeded.
Recital 12, Regulation (EU) 2024/342
In forcesince 22 Jan 2024